Gene expression analysis during tumor enhancement by the dietary phytochemical, 3,3′-diindolylmethane, in rainbow trout

Carcinogenesis

Volumn 28, Issue 7, 2007, Pages 1589-1598

  Tilton, Susan C ^a,b,c   Hendricks, Jerry D ^a   Orner, Gayle A ^b   Pereira, Cliff B ^a   Bailey, George S ^a,b   Williams, David E ^a,b  

^a OREGON STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,3' DIINDOLYLMETHANE; AFLATOXIN B1; ESTRADIOL; METHANOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; METASTASIS POTENTIAL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAINBOW TROUT; SIGNAL TRANSDUCTION; TUMOR PROMOTION; UNINDEXED SEQUENCE;

AFLATOXIN B1; ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; DIETARY SUPPLEMENTS; ESTRADIOL; GENE EXPRESSION PROFILING; INDOLES; LIVER; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCORHYNCHUS MYKISS; PLANT PREPARATIONS;

EID: 34547794727     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm017     Document Type: Article

References (48)

1. Anderton,M.J. et al. (2004) Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice. Clin. Cancer Res., 10, 5233-5241.
2. Dashwood,R.H. et al. (1989) In vivo disposition of the natural anti-carcinogen indole-3-carbinol after po administration to rainbow trout. Food Chem. Toxicol., 27, 385-392.
3. Stresser,D.M. et al. (1995) Mechanism of tumor modulation by indole-3-carbinol. Disposition and excretion in male Fischer 344 rats. Drug Metab. Dispos., 23, 965-975.
4. Bradlow,H.L. et al. (1991) Effects of dietary indole-3-carbinol on estrogen metabolism and spontaneous mammary tumors in mice. Carcinogenesis, 12, 1571-1574.
5. Kojima,T. et al. (1994) Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res., 54, 1446-1449.
6. Chen,I. et al. (1998) Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis, 19, 1631-1639.
7. Grubbs,C.J. et al. (1995) Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res., 15, 709-716.
8. Wattenberg,L.W. et al. (1978) Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res., 38, 1410-1413.
9. Bailey,G.S. et al. (1991) Modulation of mycotoxin and nitrosamine carcinogensis by indole-3-carbinol: Quantitative analysis of inhibition versus promotion. In: O'Neill,I.K. Chen,J. and Bartsch,H. (eds.) Relevance to Human Cancer of N-Nitroso Compounds. IARC Press, Lyon, France, pp. 275-280.
10. Tanaka,T. et al. (1990) Inhibitory effect of sinigrin and indole-3-carbinol on diethylnitrosamine-induced hepatocarcinogenesis in male ACI/N rats. Carcinogenesis, 11, 1403-1406.
11. Morse,M.A. et al. (1990) Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice. Cancer Res., 50 2613-2617.
12. Xu,M. et al. (1996) Protection by green tea, black tea and indole-3-carbinol against 2-amino-3-methylimidazo[4,5-f quinoline-induced DNA adducts and colonic aberrant crypts the F344 rat. Carcinogenesis, 17, 1429-1434.
13. Bradfield,C.A. et al. (1984) Effect of dietary indole-3-carbinol on intestinal and hepatic monooxygenase, glutathione S-transferase and epoxide hydrolase-activities in the rat. Food Chem. Toxicol., 22, 977-982.
14. Dashwood,R.H., et al. (1994) Anticarcinogenic activity of indole-3-carbinol acid products: Ultrasensitive bioassay by trout embryo microinjection. Cancer Res., 54, 3617-3619.
15. Kim,Y.S. et al. (2006) Targets for indole-3-carbinol in cancer prevention. J. Nutr. Biochem., 16, 65-73.
16. Aggarwal,B.B. et al. (2005) Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle, 4, 1201-1215.
17. Leong,H. et al. (2004) Potent ligand-independent estrogen receptor activation by 3,3′-diindolylmethane is mediated by cross-talk between protein kinase A and mitogen-activated protein kinase signaling pathways. Mol. Endocrinol., 18, 291-302.
18. Kim,D.J. et al. (1997) Enhancement by indole-3-carbinol of liver and thyroid gland neoplastic development in rat medium-term multiorgan carcinogenesis model. Carcinogenesis, 18, 377-381.
19. Pence,B.B. et al. (1986) Multiple dietary factors in the enhancement of dimethylhydrazine carcinogenesis: Main effect of indole-3-carbinol. J. Natl Cancer Inst., 77, 269-276.
20. Stoner,G. et al. (2002) Development of a multi-organ rat model for evaluating chemopreventive agents: Efficacy of indole-3-carbinol. Carcinogenesis, 23, 265-272.
21. Suzui,M. et al. (2005) Indole-3-carbinol inhibits the growth of human colon carcinoma cells but enhances the tumor multiplicity and volume of azoxy-methane-induced rat colon carcinogenesis. Int. J. Oncol., 27, 1391-1399.
22. Yoshida,M. et al. (2004) Dietary indole-3-carbinol promotes endometrial adenocarcinoma development in rats initiated with N ethyl-N'-nitro-N-nitrosoguanidine, with induction of cytochrome P450s in the liver and consequent modulation of estrogen metabolism. Carcinogenesis, 25, 2257-2264.
23. Bailey,G.S. et al. (1987) Initiation, promotion and inhibition of carcinogenesis in rainbow trout. Environ. Health Perspect., 71 147-153.
24. Dashwood,R.H. et al. (1991) Promotion of aflatoxin B1 carcinogenesis by the natural tumor modulator indole-3-carbinol: influence of dose, duration, and intermittent exposure on indole-3-carbinol promotional potency. Cancer Res., 51, 2362-2365.
25. 1-initiated hepatocarcinogenesis: Results from a 9000 animal tumor study. Carcinogenesis, 20, 453-458.
26. Bjeldanes,L.F. et al. (1991) Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: Comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Natl Acad. Sci. USA, 88, 9543-9547.
27. Staub,R.E. et al. (2006) Fate of 3,3′-diindolylmethane in cultured MCF-7 human breast cancer cells. Chem. Res. Toxicol., 19, 436-442.
28. Tilton,S.C. et al. (2006) Toxicogenomic profiling of the hepatic tumor promoters indole-3-carbinol, 17β-estradiol and β-naphthoflavone in rainbow trout. Toxicol. Sci., 90, 61-72.
29. Lee,B.C. et al. (1991) Toxicity of microtoxins in the feed of fish. In: Smith,J.E. (ed.) Mycotoxins and Animal Feedstuff: Natural Occurrence, Toxicity and Control. CRC Press, Boca Raton, FL, pp. 607-626.
30. Hendricks,J.D. et al. (1984) Histological progression of hepatic neoplasia in rainbow trout (Salmo gairdneri). Natl Cancer Inst. Monogr., 65, 321-336.
31. 1-induced hepatocellular carcinoma compared to adjacent liver. Toxicol. Sci. 88, 319-330.
32. Saal,H.L. et al. (2002) BioArray software environment: A platform for comprehensive management and analysis of microarray data. Genome Biol., 3, software0003, 1-0003.6.
33. Bailey,G.S. et al. (1996) Fish models for environmental carcinogenesis: The rainbow trout. Environ. Health Perspect., 104, (suppl.), 5-19.
34. Nunez,O. et al. (1989) Promotion of aflatoxin B1 hepatocarcinogenesis in rainbow trout by 17β-estradiol. Aquat. Toxicol., 15, 289-302.
35. Riby,J.E. et al. (2000) Ligand-independent activation of estrogen receptor function by 3,3′-diindolylmethane in human breast cancer cells. Biochem. Pharmacol., 60, 167-177.
36. Auborn,K.J. et al. (2003) Indole-3-carbinol is a negative regulator of estrogen. J. Nutr.,, 133, 2470S-2475S.
37. Wang,T.T.Y. et al. (2006) Estrogen receptor α as a target for indole-3-carbinol. J. Nutr. Biochem., 17, 659-664.
38. Yager,J.D. et al. (1984) Enhancement of hepatocarcinogenesis in female rats by ethinyl estradiol and mestranol but not estradiol. Cancer Res., 44, 3862-3869.
39. Shimizu,I. et al. (1998) Suppressive effect of oestradiol on chemical hepatocarcinogenesis in rats. Gut, 42, 112-119.
40. Matthews,J. et al. (2000) Differential estrogen receptor binding of estrogenic substances: A species comparison. J. Steroid Biochem. Mol. Biol., 74, 223-234.
41. Petit,F. et al. (1995) Differential functional activities of rainbow trout and human estrogen receptors expressed in the yeast Saccharomyces cerevisiae. Eur. J. Biochem., 233, 584-592.
42. Shankaran,V. et al. (2001) IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature, 410 1107-1111.
43. Kodama,T. et al. (1999) Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-2. Eur. J. Immunol., 29, 1390-1396.
44. Exon,J.H. et al. (2000) Dietary indole-3-carbinol alters immune functions in rats. J. Toxicol. Environ. Health Part A, 59, 271-279.
45. Xue,L. et al. (2005) DIM stimulates IFNγ gene expression in human breast cancer cells via the specific activation of JNK and p38 pathways. Oncogene, 24, 2343-2353.
46. Riby,J.E. et al. (2006) Activation and potentiation of interferon-γ signaling by 3,3′-diindolylmethane in MCF-7 breast cancer cells. Mol. Pharmacol., 69, 430-439.
47. Helms,M.W. et al. (2005) First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer. J. Pathol., 206, 366-376.
48. Rothhammer,T. et al. (2005) Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res., 65, 448-456.